These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8932264)

  • 1. "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
    Shapiro R; Vivas C; Scantlebury VP; Jordan ML; Gritsch HA; Neugarten J; McCauley J; Randhawa P; Irish W; Fung JJ; Hakala T; Simmons RL; Starzl TE
    Transplantation; 1996 Nov; 62(9):1242-6. PubMed ID: 8932264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of renal transplants from pediatric donors <5 yr of age.
    El-Sabrout R; Buch K
    Clin Transplant; 2005 Jun; 19(3):316-20. PubMed ID: 15877791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric renal transplantation under tacrolimus-based immunosuppression.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
    Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R
    Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of pediatric en bloc cadaver kidneys into adult recipients.
    Hobart MG; Modlin CS; Kapoor A; Boparai N; Mastroianni B; Papajcik D; Flechner SM; Goldfarb DA; Fischer R; O'Malley KJ; Novick AC
    Transplantation; 1998 Dec; 66(12):1689-94. PubMed ID: 9884260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.
    Gavela Martínez E; Avila Bernabeu AI; Sancho Calabuig A; Beltrán Catalán S; Escudero Quesada V; Pallardó Mateu LM
    Transplant Proc; 2009; 41(6):2337-8. PubMed ID: 19715913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplantation in recipients over the age of 60: the impact of donor age.
    Basar H; Soran A; Shapiro R; Vivas C; Scantlebury VP; Jordan ML; Gritsch HA; McCauley J; Randhawa P; Irish W; Hakala TR; Fung JJ
    Transplantation; 1999 Apr; 67(8):1191-3. PubMed ID: 10232574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double versus single renal allografts from aged donors.
    Andrés A; Morales JM; Herrero JC; Praga M; Morales E; Hernández E; Ortuño T; Rodício JL; Martínez MA; Usera G; Díaz R; Polo G; Aguirre F; Leiva O
    Transplantation; 2000 May; 69(10):2060-6. PubMed ID: 10852597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
    Shapiro R; Nalesnik M; McCauley J; Fedorek S; Jordan ML; Scantlebury VP; Jain A; Vivas C; Ellis D; Lombardozzi-Lane S; Randhawa P; Johnston J; Hakala TR; Simmons RL; Fung JJ; Starzl TE
    Transplantation; 1999 Dec; 68(12):1851-4. PubMed ID: 10628763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data.
    Bresnahan BA; McBride MA; Cherikh WS; Hariharan S
    Transplantation; 2001 Jul; 72(2):256-61. PubMed ID: 11477349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.
    Balachandran VP; Aull MJ; Charlton M; Afaneh C; Serur D; Leeser DB; Del Pizzo J; Kapur S
    Transplantation; 2012 Sep; 94(5):499-505. PubMed ID: 22892992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients.
    Abou-Jaoude MM; Najm R; Shaheen J; Nawfal N; Abboud S; Alhabash M; Darwish M; Mulhem A; Ojjeh A; Almawi WY
    Transplant Proc; 2005 Sep; 37(7):3025-8. PubMed ID: 16213293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
    Jordan ML; Chakrabarti P; Luke P; Shapiro R; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
    Transplantation; 2000 Jan; 69(2):265-71. PubMed ID: 10670637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of en bloc and single kidney transplantation from very young cadaveric donors.
    Satterthwaite R; Aswad S; Sunga V; Shidban H; Mendez RG; Bogaard T; Asai P; Khetan U; Magpayo M; Mendez R
    Transplantation; 1997 May; 63(10):1405-10. PubMed ID: 9175801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
    González-Roncero FM; Gentil-Govantes MÁ; González-Molina M; Rivero M; Cantarell C; Alarcón A; Franco A; Sánchez-Plumed J; Lampreabe I; Lauzurica R; González E; Romero R; Ruiz-San Millán JC; Osuna A
    Nefrologia; 2012 Jul; 32(4):446-54. PubMed ID: 22806279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of age on rejection in kidney transplantation.
    de Fijter JW
    Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.